French pharma on trial for manslaughter, for covering up possibly thousands of deaths and many other cases of injuries from their amphetamine-based diabetes drug. French equivalent of FDA is under fire too.

https://endpts.com/servier-begins-manslaughte...loss-drug/

Glad that IPIX was cautious with Kevetrin clinical trials. And also glad that Brilacidin seemingly is not absorbed systemically when the enema formulation was used -- and it seems likely the same thing will be the case with the pill form -- as this greatly reduces possible safety concerns.